Agitation and insomnia were the most common psychiatric treatment-emergent adverse events when administering eslicarbazepine acetate to youth, but they did not lead to treatment discontinuation.
All articles by Laurell Haapanen, Editor, Psychiatry Advisor
-
Latest News Your top articles for Monday
For More Personalized News -
Haymarket Medical NetworkTop Picks
-
Spotlight Course
- Loading...
Continuing Medical Education (CME/CE) Courses